JPM Thematics - Genetic Therapies C2 Fonds
80,05
EUR
-1,72
EUR
-2,10
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| PTC Therapeutics Inc | US69366J2006 | 3,51% |
| Gilead Sciences Inc | US3755581036 | 3,49% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,38% |
| Krystal Biotech Inc | US5011471027 | 3,35% |
| Amgen Inc | US0311621009 | 3,33% |
| Novartis AG Registered Shares | CH0012005267 | 3,30% |
| Bristol-Myers Squibb Co | US1101221083 | 3,29% |
| Lonza Group Ltd | CH0013841017 | 3,12% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 2,96% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,86% |
| Sonstige | 67,39% |